A family’s journey navigating an 8-year-old boy’s rare neurodegenerative CLCN6 mutation highlights diagnostic challenges and hope through emerging gene therapy research.

In research settings, including patients with neurodegenerative diseases presents challenges regarding consent, communication, and ability to participate that must be addressed in order to avoid evidence-biased care.